I worked for a company that developed some PA criteria for these drugs, I can assure you a lot of debate went into this criteria.. these two specific drugs are probably the most hotly contested drugs.  If we sold them at the 84k price tag to anyone that COULD use it, the entire insurance industry would go bankrupt, literally.  Not even an exaggeration.  While your logic is sound, the drug is cheaper than a liver transplat... not everyone who has Hep C ends up getting a liver transplant.  There&#x27;s a huge gap between the number of people who COULD use the drug (and have a MUCH better quality of life), and the people who are most qualified for it.  The drug companies are not doing the government a favor here... sorry.<p>Another side conversation that&#x27;s interesting, is who takes the $84k hit.  There&#x27;s sound logic that it&#x27;s cheaper to give the drug NOW vs paying for surgery LATER... but what if i&#x27;m not your insurer when you need it.  With obamacare, you can&#x27;t be denied because of pre-existing conditions... so it&#x27;s interesting math.